Widely read:
Indian equity markets opened on a tentatively positive note on Wednesday, tracking upbeat global cues. Early in the day, the Sensex rose over 150 points and Nifty climbed past 24,550, reflecting a modest rebound after the previous session’s sell-off. However, overall sentiment was cautious. Investors remained wary ahead of the Reserve Bank of India’s upcoming policy announcement later in the week. Recent data showing persistent foreign fund outflows also weighed on confidence – foreign institutional investors (FIIs) were net sellers of about Rs 2,854 crore in the prior session, even as domestic institutions absorbed roughly Rs 5,908 crore of equities. Moreover, rising global uncertainties (from US fiscal concerns to trade tensions) and the looming monsoon season kept traders on edge.
On the bright side, the timely onset of monsoon rains in Kerala bolstered hopes for a good agricultural season, potentially easing inflation and supporting rural demand. Overall, the BSE 500 index opened flat to slightly higher, with market breadth mixed as stock-specific news drove outsized moves in certain counters.
Top 5 Gainers in the BSE 500 and Their Triggers
Garden Reach Shipbuilders & Engineers (GRSE) +6.93 per cent:
Shares of defence shipyard GRSE surged to a fresh record high (~Rs 3,464) after the company signed a landmark MoU with Norway’s Kongsberg to build India’s first-ever polar research vessel. This development bolsters GRSE’s order book and strategic profile. The news, coupled with broader momentum in the defence sector amid geopolitical tensions, propelled GRSE stock nearly 7 per cent higher, leading the BSE 500 gainers.
AstraZeneca Pharma India (ASTRAZEN) +5.21 per cent:
AstraZeneca’s stock jumped over 5 per cent, extending its rally following strong quarterly earnings. The pharma major’s Q4 FY25 net profit soared 48 per cent year-on-year to Rs 58.25 crore, with revenue up 25 per cent, driven by robust growth in oncology and rare disease drug sales. The better-than-expected results and improving margins have boosted investor confidence, pushing the stock to multi-year highs. Positive sentiment in healthcare stocks and defensive positioning in a volatile market also contributed to AstraZeneca’s gains.
Cochin Shipyard (COCHINSHIP) +3.95 per cent:
The shipbuilder continued its upward trajectory, adding ~4 per cent after an even stronger move in the previous session. Defence and shipbuilding stocks remained in favour as global military spending themes play out. On June 3, Cochin Shipyard jumped over 5 per cent to approximately Rs 2,019, outperforming a weak broader market as the Nifty Defence index rose on news of rising geopolitical tensions. The positive momentum carried into today’s trade. Additionally, recent reports about Cochin Shipyard exploring collaborations with global majors (e.g. a potential tie-up with HD Hyundai) and its strong order pipeline kept the stock buoyant.
TBO Tek (TBOTEK) +3.51 per cent:
The online travel platform’s stock gained over 3 per cent, buoyed by impressive earnings and continued post-IPO interest. TBO Tek recently reported a 26 per cent year-over-year (YoY) surge in Q4 FY25 profit to ~Rs 59 crore, with revenue increasing by ~21 per cent to Rs 446 crore. These results underscore robust growth in travel bookings and improvements in the take rate. Notably, a slew of mutual funds took stakes in TBO Tek via bulk deals in March, and the stock had seen some profit-taking last week. This week’s solid earnings helped renew buying interest, making TBO Tek one of the top mid-cap gainers.
Motilal Oswal Financial Services (MOTILALOFS) +3.06 per cent:
Shares of the financial services firm rose ~3 per cent, possibly due to value buying and a fundamentally sound full-year performance. Despite a one-off loss in the March quarter, Motilal Oswal’s consolidated FY2025 revenue grew to Rs 8,339 crore (up from Rs 7,068 crore in FY24) and annual net profit inched up to Rs 2,508 crore. The company’s asset management and broking businesses have remained resilient. With the RBI expected to cut rates (which could stimulate credit and capital markets) and gold prices at record highs (boosting its wealth management outlook), investors rotated into financial stocks like Motilal Oswal. The stock’s inclusion in trading “buy” lists by some brokerages may have also contributed to the uptick.
Top 5 Losers in the BSE 500 and Their Triggers
Sun Pharma Advanced Research Co. (SPARC) –19.30 per cent:
SPARC nosedived by about 19 per cent, hitting a new low as investors reacted to negative developments in its drug pipeline and unusual trading activity. The speciality R&D firm recently halted a key clinical trial (the PROSEEK study for Parkinson’s disease) after interim data showed its drug Vodobatinib was no better than a placebo. This setback, first disclosed last year, has weighed on sentiment. In late May, exchanges even sought clarification from SPARC regarding a sudden surge in volumes and volatility. With no positive catalysts and a string of losses (four consecutive quarterly net losses), the stock succumbed to heavy selling. The steep one-day plunge likely reflects stop-loss triggers and exit by some institutional holders, underscoring concerns about SPARC’s R&D productivity and funding needs.
Aditya Birla Fashion & Retail (ABFRL) –11.42 per cent:
ABFRL’s stock tanked 10–11 per cent as a large block trade hit the market. Roughly 7.6 crore shares (6.2 per cent equity) worth Rs 617 crore changed hands at Rs 81 per share in early trade. This was prompted by Walmart-owned Flipkart’s decision to offload its entire ~6 per cent stake in ABFRL via a block deal, as part of Flipkart’s strategic portfolio shift. The stake sale by Flipkart (executed at a 7.6 per cent discount to the prior closing price) spooked investors, even though ABFRL’s recent results showed narrowing losses (Q4 FY25 net loss of Rs 23.5 crore, significantly improved from a Rs 266 crore loss a year ago). The stock’s sharp fall reflects short-term supply pressure and concern over why a key investor is exiting. Analysts note that ABFRL’s long-term prospects, with its portfolio of popular brands including Pantaloons and Allen Solly, remain intact. Still, near-term sentiment is weak until the overhang from this stake sale is cleared.
MMTC –4.67 per cent:
Metals trading PSU MMTC extended its decline, dropping nearly 5 per cent. This comes on the heels of a disappointing earnings report: the company’s Q4 FY25 net profit plunged 96.8 per cent YoY to just Rs 2.23 crore, on revenue that slumped 64 per cent. The abysmally low results marked a stark reversal for MMTC, which had seen its stock rally by over 50 per cent in May before the numbers were announced. Profit-taking set in immediately after the results (the stock fell ~9 per cent on result day), and the sell-off continued today as investors reassessed the company’s prospects. Additionally, with gold and commodity trading volumes under pressure and no clear turnaround plan from management, MMTC saw further unwinding of positions.
India Cements (INDIACEM) –3.34 per cent:
India Cements shares declined ~3.3 per cent, largely due to profit-booking after a recent rally. Earlier this week, the stock had climbed over 5 per cent in two days, buoyed by a surprising return to profitability in Q4 FY25 – the company reported a Rs 14.7 crore quarterly profit, compared to losses in previous quarters. That earnings boost, along with optimism around industry consolidation, lifted the stock to around Rs 340. However, at these higher levels, and with the approach of monsoon season (which typically softens cement demand), some investors chose to lock in gains. The broader market volatility also contributed to the pullback. Analysts note that India Cements’ annual losses have been narrowing, but sustaining profitability will be key for further stock upside.
Hindustan Zinc (HINDZINC) –2.87 per cent:
The mining major’s stock slipped nearly 3 per cent, underperforming amid a mixed commodities market. Fluctuating zinc and lead prices globally have kept earnings outlooks in check – zinc is hovering around $2,800/ton with no clear uptrend yet. Additionally, Hindustan Zinc has faced corporate uncertainty; its plan to demerge businesses (zinc/lead, silver, recycling) to unlock value was put on hold after the government (which holds 29.5 per cent in HZL) opposed the move. This lack of clarity on corporate restructuring, coupled with parent company Vedanta’s well-known debt issues, has made investors cautious. Despite posting strong fiscal 2025 profits on higher volumes, HZL’s stock has been range-bound. Today’s drop likely reflects routine trading volatility and a slight cool-off in metal stocks, rather than any fresh fundamental damage.
Conclusion
In summary, the BSE 500’s top gainers on June 4 were powered by stock-specific positive triggers – from defence contract wins to stellar earnings – even as the broader market mood remained guarded. Losers, on the other hand, were driven by adverse news, such as a major stake sale, weak results, or sectoral headwinds. The market’s flat opening belied the churn underneath, as investors digested a mix of domestic cues (RBI policy expectations and monsoon updates) and global signals (U.S. market strength versus global uncertainty).
Going forward, overall sentiment will hinge on policy outcomes and macro developments, but stock-specific action is likely to remain high as seen in today’s session.
Disclaimer: This story was created with the assistance of artificial intelligence and is intended for informational purposes only. Please take it with a grain of salt and conduct your own research or consult a financial advisor before making any investment decisions.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
Ask Value Research 
New episodes every Friday 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
